Refractive surgery is a surgical method to change the refractive state of the eye, so that external objects can be clearly imaged on the retina to improve visual function. The concept of refractive surgery is not only used in the correction of common refractive errors (myopia, hyperopia, etc.), but also in cataract surgery, corneal transplantation, and the treatment of presbyopia. Refractive eye surgery is optional eye surgery used to improve the refractive state of the eye and decrease or eliminate dependency on glasses or contact lenses. The most common methods today use excimer lasers to reshape the curvature of the cornea. Refractive eye surgeries are used to treat common vision disorders such as myopia, hyperopia, presbyopia and astigmatism.
Highlights
The global Refractive Surgery market was valued at US$ 11130 million in 2022 and is anticipated to reach US$ 22050 million by 2029, witnessing a CAGR of 12.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global top two manufacturers of Refractive Surgery occupied for a share about 10 percent, key players are Aier Eye Hospital Group and Huaxia Eye Hospital Group, etc. China is the largest market of Refractive Surgery , with a share nearly 40%, followed by Americas.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Refractive Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Refractive Surgery.
The Refractive Surgery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Refractive Surgery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Refractive Surgery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bascom Palmer Eye Institute
Wills Eye Hospital
EuroEyes
Juntendo University Hospital
Teikyo University Hospital
Aier Eye Hospital Group
Huaxia Eye Hospital Group
Sanno Hospital
Optical Express
Optimax
Ultralase
Optegra
Focus Clinics
University of Iowa Hospitals & Clinics
National University Hospital
Bumrungrad International Hospital
Ottawa General Hospital
UCSF Health
Guangzheng Eye Hospital
C-Mer Eye Care
Liaoning He Eye Hospital
Beijing Tongren Hospital
Eye-Q
Aravind
Segment by Type
Corneal Refractive Surgery
ICL Surgery
Segment by Application
Hospital
Eye Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Refractive Surgery companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Refractive Surgery 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Corneal Refractive Surgery
1.2.3 ICL Surgery
1.3 麻豆原创 by Application
1.3.1 Global Refractive Surgery 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Eye Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Refractive Surgery 麻豆原创 Perspective (2018-2029)
2.2 Refractive Surgery Growth Trends by Region
2.2.1 Global Refractive Surgery 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Refractive Surgery Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Refractive Surgery Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Refractive Surgery 麻豆原创 Dynamics
2.3.1 Refractive Surgery Industry Trends
2.3.2 Refractive Surgery 麻豆原创 Drivers
2.3.3 Refractive Surgery 麻豆原创 Challenges
2.3.4 Refractive Surgery 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Refractive Surgery Players by Revenue
3.1.1 Global Top Refractive Surgery Players by Revenue (2018-2023)
3.1.2 Global Refractive Surgery Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Refractive Surgery 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Refractive Surgery Revenue
3.4 Global Refractive Surgery 麻豆原创 Concentration Ratio
3.4.1 Global Refractive Surgery 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Refractive Surgery Revenue in 2022
3.5 Refractive Surgery Key Players Head office and Area Served
3.6 Key Players Refractive Surgery Product Solution and Service
3.7 Date of Enter into Refractive Surgery 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Refractive Surgery Breakdown Data by Type
4.1 Global Refractive Surgery Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Refractive Surgery Forecasted 麻豆原创 Size by Type (2024-2029)
5 Refractive Surgery Breakdown Data by Application
5.1 Global Refractive Surgery Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Refractive Surgery Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Refractive Surgery 麻豆原创 Size (2018-2029)
6.2 North America Refractive Surgery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Refractive Surgery 麻豆原创 Size by Country (2018-2023)
6.4 North America Refractive Surgery 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Refractive Surgery 麻豆原创 Size (2018-2029)
7.2 Europe Refractive Surgery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Refractive Surgery 麻豆原创 Size by Country (2018-2023)
7.4 Europe Refractive Surgery 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Refractive Surgery 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Refractive Surgery 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Refractive Surgery 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Refractive Surgery 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Refractive Surgery 麻豆原创 Size (2018-2029)
9.2 Latin America Refractive Surgery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Refractive Surgery 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Refractive Surgery 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Refractive Surgery 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Refractive Surgery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Refractive Surgery 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Refractive Surgery 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bascom Palmer Eye Institute
11.1.1 Bascom Palmer Eye Institute Company Detail
11.1.2 Bascom Palmer Eye Institute Business Overview
11.1.3 Bascom Palmer Eye Institute Refractive Surgery Introduction
11.1.4 Bascom Palmer Eye Institute Revenue in Refractive Surgery Business (2018-2023)
11.1.5 Bascom Palmer Eye Institute Recent Development
11.2 Wills Eye Hospital
11.2.1 Wills Eye Hospital Company Detail
11.2.2 Wills Eye Hospital Business Overview
11.2.3 Wills Eye Hospital Refractive Surgery Introduction
11.2.4 Wills Eye Hospital Revenue in Refractive Surgery Business (2018-2023)
11.2.5 Wills Eye Hospital Recent Development
11.3 EuroEyes
11.3.1 EuroEyes Company Detail
11.3.2 EuroEyes Business Overview
11.3.3 EuroEyes Refractive Surgery Introduction
11.3.4 EuroEyes Revenue in Refractive Surgery Business (2018-2023)
11.3.5 EuroEyes Recent Development
11.4 Juntendo University Hospital
11.4.1 Juntendo University Hospital Company Detail
11.4.2 Juntendo University Hospital Business Overview
11.4.3 Juntendo University Hospital Refractive Surgery Introduction
11.4.4 Juntendo University Hospital Revenue in Refractive Surgery Business (2018-2023)
11.4.5 Juntendo University Hospital Recent Development
11.5 Teikyo University Hospital
11.5.1 Teikyo University Hospital Company Detail
11.5.2 Teikyo University Hospital Business Overview
11.5.3 Teikyo University Hospital Refractive Surgery Introduction
11.5.4 Teikyo University Hospital Revenue in Refractive Surgery Business (2018-2023)
11.5.5 Teikyo University Hospital Recent Development
11.6 Aier Eye Hospital Group
11.6.1 Aier Eye Hospital Group Company Detail
11.6.2 Aier Eye Hospital Group Business Overview
11.6.3 Aier Eye Hospital Group Refractive Surgery Introduction
11.6.4 Aier Eye Hospital Group Revenue in Refractive Surgery Business (2018-2023)
11.6.5 Aier Eye Hospital Group Recent Development
11.7 Huaxia Eye Hospital Group
11.7.1 Huaxia Eye Hospital Group Company Detail
11.7.2 Huaxia Eye Hospital Group Business Overview
11.7.3 Huaxia Eye Hospital Group Refractive Surgery Introduction
11.7.4 Huaxia Eye Hospital Group Revenue in Refractive Surgery Business (2018-2023)
11.7.5 Huaxia Eye Hospital Group Recent Development
11.8 Sanno Hospital
11.8.1 Sanno Hospital Company Detail
11.8.2 Sanno Hospital Business Overview
11.8.3 Sanno Hospital Refractive Surgery Introduction
11.8.4 Sanno Hospital Revenue in Refractive Surgery Business (2018-2023)
11.8.5 Sanno Hospital Recent Development
11.9 Optical Express
11.9.1 Optical Express Company Detail
11.9.2 Optical Express Business Overview
11.9.3 Optical Express Refractive Surgery Introduction
11.9.4 Optical Express Revenue in Refractive Surgery Business (2018-2023)
11.9.5 Optical Express Recent Development
11.10 Optimax
11.10.1 Optimax Company Detail
11.10.2 Optimax Business Overview
11.10.3 Optimax Refractive Surgery Introduction
11.10.4 Optimax Revenue in Refractive Surgery Business (2018-2023)
11.10.5 Optimax Recent Development
11.11 Ultralase
11.11.1 Ultralase Company Detail
11.11.2 Ultralase Business Overview
11.11.3 Ultralase Refractive Surgery Introduction
11.11.4 Ultralase Revenue in Refractive Surgery Business (2018-2023)
11.11.5 Ultralase Recent Development
11.12 Optegra
11.12.1 Optegra Company Detail
11.12.2 Optegra Business Overview
11.12.3 Optegra Refractive Surgery Introduction
11.12.4 Optegra Revenue in Refractive Surgery Business (2018-2023)
11.12.5 Optegra Recent Development
11.13 Focus Clinics
11.13.1 Focus Clinics Company Detail
11.13.2 Focus Clinics Business Overview
11.13.3 Focus Clinics Refractive Surgery Introduction
11.13.4 Focus Clinics Revenue in Refractive Surgery Business (2018-2023)
11.13.5 Focus Clinics Recent Development
11.14 University of Iowa Hospitals & Clinics
11.14.1 University of Iowa Hospitals & Clinics Company Detail
11.14.2 University of Iowa Hospitals & Clinics Business Overview
11.14.3 University of Iowa Hospitals & Clinics Refractive Surgery Introduction
11.14.4 University of Iowa Hospitals & Clinics Revenue in Refractive Surgery Business (2018-2023)
11.14.5 University of Iowa Hospitals & Clinics Recent Development
11.15 National University Hospital
11.15.1 National University Hospital Company Detail
11.15.2 National University Hospital Business Overview
11.15.3 National University Hospital Refractive Surgery Introduction
11.15.4 National University Hospital Revenue in Refractive Surgery Business (2018-2023)
11.15.5 National University Hospital Recent Development
11.16 Bumrungrad International Hospital
11.16.1 Bumrungrad International Hospital Company Detail
11.16.2 Bumrungrad International Hospital Business Overview
11.16.3 Bumrungrad International Hospital Refractive Surgery Introduction
11.16.4 Bumrungrad International Hospital Revenue in Refractive Surgery Business (2018-2023)
11.16.5 Bumrungrad International Hospital Recent Development
11.17 Ottawa General Hospital
11.17.1 Ottawa General Hospital Company Detail
11.17.2 Ottawa General Hospital Business Overview
11.17.3 Ottawa General Hospital Refractive Surgery Introduction
11.17.4 Ottawa General Hospital Revenue in Refractive Surgery Business (2018-2023)
11.17.5 Ottawa General Hospital Recent Development
11.18 UCSF Health
11.18.1 UCSF Health Company Detail
11.18.2 UCSF Health Business Overview
11.18.3 UCSF Health Refractive Surgery Introduction
11.18.4 UCSF Health Revenue in Refractive Surgery Business (2018-2023)
11.18.5 UCSF Health Recent Development
11.19 Guangzheng Eye Hospital
11.19.1 Guangzheng Eye Hospital Company Detail
11.19.2 Guangzheng Eye Hospital Business Overview
11.19.3 Guangzheng Eye Hospital Refractive Surgery Introduction
11.19.4 Guangzheng Eye Hospital Revenue in Refractive Surgery Business (2018-2023)
11.19.5 Guangzheng Eye Hospital Recent Development
11.20 C-Mer Eye Care
11.20.1 C-Mer Eye Care Company Detail
11.20.2 C-Mer Eye Care Business Overview
11.20.3 C-Mer Eye Care Refractive Surgery Introduction
11.20.4 C-Mer Eye Care Revenue in Refractive Surgery Business (2018-2023)
11.20.5 C-Mer Eye Care Recent Development
11.21 Liaoning He Eye Hospital
11.21.1 Liaoning He Eye Hospital Company Detail
11.21.2 Liaoning He Eye Hospital Business Overview
11.21.3 Liaoning He Eye Hospital Refractive Surgery Introduction
11.21.4 Liaoning He Eye Hospital Revenue in Refractive Surgery Business (2018-2023)
11.21.5 Liaoning He Eye Hospital Recent Development
11.22 Beijing Tongren Hospital
11.22.1 Beijing Tongren Hospital Company Detail
11.22.2 Beijing Tongren Hospital Business Overview
11.22.3 Beijing Tongren Hospital Refractive Surgery Introduction
11.22.4 Beijing Tongren Hospital Revenue in Refractive Surgery Business (2018-2023)
11.22.5 Beijing Tongren Hospital Recent Development
11.23 Eye-Q
11.23.1 Eye-Q Company Detail
11.23.2 Eye-Q Business Overview
11.23.3 Eye-Q Refractive Surgery Introduction
11.23.4 Eye-Q Revenue in Refractive Surgery Business (2018-2023)
11.23.5 Eye-Q Recent Development
11.24 Aravind
11.24.1 Aravind Company Detail
11.24.2 Aravind Business Overview
11.24.3 Aravind Refractive Surgery Introduction
11.24.4 Aravind Revenue in Refractive Surgery Business (2018-2023)
11.24.5 Aravind Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bascom Palmer Eye Institute
Wills Eye Hospital
EuroEyes
Juntendo University Hospital
Teikyo University Hospital
Aier Eye Hospital Group
Huaxia Eye Hospital Group
Sanno Hospital
Optical Express
Optimax
Ultralase
Optegra
Focus Clinics
University of Iowa Hospitals & Clinics
National University Hospital
Bumrungrad International Hospital
Ottawa General Hospital
UCSF Health
Guangzheng Eye Hospital
C-Mer Eye Care
Liaoning He Eye Hospital
Beijing Tongren Hospital
Eye-Q
Aravind
听
听
*If Applicable.
